Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders.
This paper discusses clinical experience of the use of desmopressin in patients with either congenital or acquired bleeding disorders. The bleeding disorders reviewed herein are haemophilia A, von Willebrand's disease and platelet function disorders (congenital bleeding disorders); uraemia, liver cirrhosis and drug-induced bleeding (acquired bleeding disorders).
Cattaneo
M
M
Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Milan, Italy.
D003894:Deamino Arginine Vasopressin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006470:Hemorrhage / Q000151:congenital / Q000188:drug therapy*; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D013927:Thrombosis / Q000139:chemically induced; D014842:von Willebrand Diseases / Q000188:drug therapy
D006490:Hemostatics; D003894:Deamino Arginine Vasopressin